Validation of plasma core biomarkers of Alzheimer's disease: A multicenter study in usual practice conditions

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Plasma Phosphorylated Tau 217 and Amyloid Burden in Older Adults Without Cognitive Impairment2025
2. 2Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer’s disease2024 · 22 citations
3. 3Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup2024 · 2,686 citations
4. 4The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease2011 · 10,433 citations
5. 5Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau2021 · 265 citations